146 related articles for article (PubMed ID: 17849118)
1. Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer.
Saif MW; Hashmi S
Cancer Chemother Pharmacol; 2008 Mar; 61(3):349-54. PubMed ID: 17849118
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced hyperexcitability syndrome in a patient with pancreatic cancer.
Saadati H; Saif MW
JOP; 2009 Jul; 10(4):459-61. PubMed ID: 19581758
[TBL] [Abstract][Full Text] [Related]
3. Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.
Saif MW; Syrigos K; Kaley K; Isufi I
Anticancer Res; 2010 Jul; 30(7):2927-33. PubMed ID: 20683034
[TBL] [Abstract][Full Text] [Related]
4. Acute oxaliplatin-induced peripheral nerve hyperexcitability.
Wilson RH; Lehky T; Thomas RR; Quinn MG; Floeter MK; Grem JL
J Clin Oncol; 2002 Apr; 20(7):1767-74. PubMed ID: 11919233
[TBL] [Abstract][Full Text] [Related]
5. [Promising effects of pregabalin in the treatment of oxaliplatin-induced sensory neuropathy in patients with colorectal carcinoma].
Nagahara H; Noda E; Maeda K; Inoue T; Hirakawa T; Hasegawa T; Shibutani M; Hirakawa K
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1181-3. PubMed ID: 24047775
[TBL] [Abstract][Full Text] [Related]
6. [Meta-analysis on gemcitabine of fixed-dose rate infusion plus oxaliplatin as first-line therapy for advanced pancreatic cancer].
Xie DR; Liang HL; Yang Q; Guo SS; Jiang ZM
Ai Zheng; 2007 Aug; 26(8):895-9. PubMed ID: 17697555
[TBL] [Abstract][Full Text] [Related]
7. Gemox: a widely useful therapy against solid tumors-review and personal experience.
Meriggi F; Zaniboni A
J Chemother; 2010 Oct; 22(5):298-303. PubMed ID: 21123151
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
Franciosi V; Barbieri R; Aitini E; Vasini G; Cacciani GC; Capra R; Camisa R; Cascinu S
Lung Cancer; 2003 Jul; 41(1):101-6. PubMed ID: 12826318
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
Louvet C; Labianca R; Hammel P; Lledo G; Zampino MG; André T; Zaniboni A; Ducreux M; Aitini E; Taïeb J; Faroux R; Lepere C; de Gramont A; ;
J Clin Oncol; 2005 May; 23(15):3509-16. PubMed ID: 15908661
[TBL] [Abstract][Full Text] [Related]
10. Atypical presentation of acute neurotoxicity secondary to oxaliplatin.
Uña E
J Oncol Pharm Pract; 2010 Dec; 16(4):280-2. PubMed ID: 20015928
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer].
Shi YX; Xu RH; Jiang WQ; Zhang L; Lin TY; Li YH; Xia ZJ; Luo HY; Han B; Wang F; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1381-4. PubMed ID: 18076807
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).
Okano N; Morizane C; Nomura S; Takahashi H; Tsumura H; Satake H; Mizuno N; Tsuji K; Shioji K; Asagi A; Yasui K; Kitagawa S; Kashiwada T; Ishiguro A; Kanai M; Ueno M; Ogura T; Shimizu S; Tobimatsu K; Motoya M; Nakashima K; Ikeda M; Okusaka T; Furuse J
Int J Clin Oncol; 2020 Oct; 25(10):1835-1843. PubMed ID: 32535711
[TBL] [Abstract][Full Text] [Related]
14. Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study.
Tsavaris N; Kosmas C; Skopelitis H; Gouveris P; Kopterides P; Loukeris D; Sigala F; Zorbala-Sypsa A; Felekouras E; Papalambros E
Invest New Drugs; 2005 Aug; 23(4):369-75. PubMed ID: 16012797
[TBL] [Abstract][Full Text] [Related]
15. Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate.
Wrzesinski SH; McGurk ML; Donovan CT; Ferencz TM; Saif MW
Anticancer Drugs; 2007 Jul; 18(6):721-4. PubMed ID: 17762403
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats.
Aoki M; Kurauchi Y; Mori A; Nakahara T; Sakamoto K; Ishii K
Biol Pharm Bull; 2014; 37(2):322-6. PubMed ID: 24492729
[TBL] [Abstract][Full Text] [Related]
17. Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
Leonard GD; Wright MA; Quinn MG; Fioravanti S; Harold N; Schuler B; Thomas RR; Grem JL
BMC Cancer; 2005 Sep; 5():116. PubMed ID: 16168057
[TBL] [Abstract][Full Text] [Related]
18. [Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].
Kowalski T; Maier C; Reinacher-Schick A; Schlegel U
Schmerz; 2008 Feb; 22(1):16-23. PubMed ID: 17578604
[TBL] [Abstract][Full Text] [Related]
19. [Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas].
Obayashi K; Ohwada S; Sunose Y; Yamamoto K; Igarashi R; Hamada K; Takeyoshi I; Horiuchi R
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1915-7. PubMed ID: 19011342
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer.
Ch'ang HJ; Huang CL; Wang HP; Shiah HS; Chang MC; Jan CM; Chen JS; Tien YW; Hwang TL; Lin JT; Cheng AL; Whang-Peng J; Chen LT
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1173-9. PubMed ID: 19319535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
